Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant humanised anti-human interleukin-1 beta monoclonal antibody

EU orphan designation number: EU/3/10/796   
Active ingredient: Recombinant humanised anti-human interleukin-1 beta monoclonal antibody
Indication: Treatment of Behçet's disease
Sponsor: XOMA UK Limited
c/o Arnold & Porter (UK) LLP, Tower 42, 25 Old Broad Street, London EC2N 1HQ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/10/2010 Orphan designation EMA/OD/062/10 (2010)6941 of 01/10/2010
14/12/2011 Transfer of orphan designation EMA/OD/062/10/T/01 (2011)9426 of 09/12/2011
02/03/2016 Transfer of orphan designation EMA/OD/062/10/T/02 (2016)1374 of 29/02/2016